Singapore’s Health System Holds Promise To Develop Drug Monitoring Devices
This article was originally published in PharmAsia News
Executive Summary
With Singapore’s biomedical infrastructure and small population, it is an ideal place to test devices that could redefine the way therapies are developed and monitored.